Centogene N.V.
CNTGF
$0.1411
$0.0118.46%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 52.49M | 52.94M | 53.07M | 51.45M | 49.84M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 52.49M | 52.94M | 53.07M | 51.45M | 49.84M |
| Cost of Revenue | 33.35M | 32.63M | 31.72M | 30.18M | 28.99M |
| Gross Profit | 19.14M | 20.31M | 21.35M | 21.27M | 20.86M |
| SG&A Expenses | 49.71M | 48.56M | 47.15M | 45.71M | 44.38M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -4.59M | -4.33M | -4.03M | -3.61M | -3.86M |
| Total Operating Expenses | 91.84M | 91.57M | 90.78M | 89.24M | 87.98M |
| Operating Income | -39.35M | -38.62M | -37.71M | -37.79M | -38.13M |
| Income Before Tax | -38.10M | -40.31M | -42.35M | -41.62M | -40.95M |
| Income Tax Expenses | 310.70K | 126.40K | -59.00K | 120.30K | 117.80K |
| Earnings from Continuing Operations | -38.41 | -40.44 | -42.29 | -41.74 | -41.07 |
| Earnings from Discontinued Operations | -- | 368.90K | 732.70K | 2.37M | 7.54M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -38.41M | -40.07M | -41.56M | -39.37M | -33.53M |
| EBIT | -39.35M | -38.62M | -37.71M | -37.79M | -38.13M |
| EBITDA | -32.98M | -31.96M | -30.55M | -30.41M | -28.52M |
| EPS Basic | -1.37 | -1.44 | -1.51 | -1.44 | -1.28 |
| Normalized Basic EPS | -1.02 | -0.99 | -0.96 | -0.95 | -0.99 |
| EPS Diluted | -1.38 | -1.45 | -1.51 | -1.44 | -1.29 |
| Normalized Diluted EPS | -1.02 | -0.99 | -0.96 | -0.95 | -0.99 |
| Average Basic Shares Outstanding | 112.65M | 111.29M | 109.93M | 109.37M | 104.73M |
| Average Diluted Shares Outstanding | 112.65M | 111.29M | 109.93M | 109.37M | 104.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
